InvestorsHub Logo
Followers 0
Posts 56
Boards Moderated 0
Alias Born 12/16/2017

Re: None

Tuesday, 01/23/2018 8:34:28 PM

Tuesday, January 23, 2018 8:34:28 PM

Post# of 428
I totally agree with your comments on Agora. Let's forget about them and focus on the real things Promis has to offer. Their prion targeting therapy using PMN310 is the best hope on the horizon for halting or slowing the progress of Alzheimer's disease. I believe that the clinical trials will be expedited now that they have found that increasing the dosage does not cause additional brain swelling. This is huge because all the research done by big pharma could not achieve these same results. A small company like Promis may not have the ways and means to bring a drug like PMN310 to market like a company like Pfizer would. I'm sure big pharma is watching this company very closely. Then there is the question of what a large company would offer Promis to acquire them . Remember that Promis has only about 230,000,000 ( 230 million ) shares in issue. I think a fair price to Promis and it's shareholders would be around $11.5 billion. That would represent a share price of $ 50 and 1$11.5 billion would be cheap to a large pharma that would eventually make tons more due to the extreme numbers of patients around the world this drug could help. I also believe that the trials are further along than may have been revealed and an announcement may not be that far in the future. I think I will sit back, relax and know that I am holding onto something that could be absolutely huge. Time will tell!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMN News